Table 1 Patients’ characteristics
| n | % | |
|---|---|---|
| Histology N = 42 | ||
| Clear cell | 13 | 31.0% |
| Papillary serous | 20 | 47.6% |
| Mixed | 9 | 21.4% |
| FIGO stage N = 42 | ||
| IA | 23 | 54.8% |
| IB | 4 | 9.5% |
| II | 4 | 9.5% |
| IIIA | 1 | 2.4% |
| IIIB | 1 | 2.4% |
| IIIC | 9 | 21.4% |
| Local tumors spread N = 42 | ||
| pT1a | 26 | 61.9% |
| pT1b | 6 | 14.3% |
| pT2 | 5 | 11.9% |
| pT3a | 4 | 9.5% |
| pT3b | 1 | 2.4% |
| Lymph node status N = 35 | ||
| pN0 | 26 | 74.3% |
| pN1 | 9 | 25.7% |
| Lymphangiosis N = 41 | ||
| L0 | 33 | 80.5% |
| L1 | 8 | 19.5% |
| Haemangiosis N = 41 | ||
| V0 | 34 | 82.9% |
| V1 | 7 | 17.1% |
| Resection status N = 42 | ||
| R0 | 36 | 85.7% |
| R1 | 6 | 14.3% |